Company Growth (employees)
Celgene Corporation was founded in 1986 and is headquartered in Summit, US
Key People at Celgene Corporation
Mark Alles
Chief Executive Officer
Robert Hugin
Executive Chairman
Jacqualyn Fouse
President and Chief Operating Officer
Peter Kellogg
Executive Vice President and Chief Financial Officer
Celgene Corporation Office Locations
Celgene Corporation has offices in Summit, Boudry and Singapore
Summit, US (HQ)
86 Morris Ave
Singapore, SG
200 Newton Rd
Boudry, CH
1 Route De Perreux
Celgene Corporation Data and Metrics
Celgene Corporation Financial Metrics
Celgene Corporation's revenue was reported to be $11.2 b in FY, 2016 which is a 21% increase from the previous period.
$, USD
Revenue (FY, 2016) | 11.2 b |
Revenue growth (FY, 2015 - FY, 2016), % | 21% |
Gross profit (FY, 2016) | 10.8 b |
Gross profit margin (FY, 2016), % | 96% |
Net income (FY, 2016) | 2 b |
EBIT (FY, 2016) | 3.2 b |
Market capitalization (22-Jun-2017) | 104.4 b |
Closing share price (22-Jun-2017) | 132.8 |
Cash (31-Dec-2016) | 6.2 b |
EV | 98.7 b |
Celgene Corporation's current market capitalization is $104.4 b.
- Source: SEC Filings
| $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 6.5 b | 7.7 b | 9.3 b | 11.2 b |
Revenue growth, % | 18% | 21% | 21% | |
Cost of goods sold | 340.4 m | 385.9 m | 420.1 m | 438 m |
Gross profit | 6.2 b | 7.3 b | 8.8 b | 10.8 b |
Gross profit Margin, % | 95% | 95% | 95% | 96% |
Operating expense total | 4.7 b | 5.2 b | 7 b | 8.1 b |
EBIT | 1.8 b | 2.5 b | 2.3 b | 3.2 b |
EBIT margin, % | 28% | 33% | 24% | 28% |
Interest expense | 91.6 m | 176.1 m | 310.6 m | 500.1 m |
Pre tax profit | 1.7 b | 2.3 b | 2 b | 2.4 b |
Income tax expense | 215.5 m | 327.5 m | 421.5 m | 373.3 m |
Net Income | 1.4 b | 2 b | 1.6 b | 2 b |
- Source: SEC Filings
| $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 3.2 b | 4.1 b | 4.9 b | 6.2 b |
Inventories | 340.4 m | 393.1 m | 443.4 m | 497.9 m |
Current Assets | 7.6 b | 9.7 b | 9.4 b | 10.9 b |
PP&E | 593.4 m | 642.6 m | 814.1 m | 929.8 m |
Goodwill | 2 b | 2.2 b | 4.9 b | 4.9 b |
Total Assets | 13.4 b | 17.3 b | 27.1 b | 28.1 b |
Accounts Payable | 156.2 m | 198.2 m | 240.8 m | 247.1 m |
Total Debt | 544.8 m | 605.9 m | 500.7 m | |
Current Liabilities | 1.9 b | 2.1 b | 2 b | 3 b |
Additional Paid-in Capital | 8.7 b | 9.8 b | 11.1 b | 12.4 b |
Retained Earnings | 4.5 b | 6.5 b | 8.1 b | 10.1 b |
Total Equity | 5.6 b | 6.5 b | 5.9 b | 6.6 b |
Debt to Equity Ratio | 0.1 x | 0.1 x | 0.1 x | |
Debt to Assets Ratio | 0 x | 0 x | 0 x | |
Financial Leverage | 2.4 x | 2.7 x | 4.6 x | 4.3 x |
| $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 1.4 b | 2 b | 1.6 b | 2 b |
Accounts Receivable | (101.4 m) | (166.3 m) | (304.7 m) | (222.4 m) |
Inventories | (89.7 m) | (56.5 m) | (50.6 m) | (55.3 m) |
Cash From Operating Activities | 2.2 b | 2.8 b | 2.5 b | 4 b |
Capital Expenditures | (119.7 m) | (150.3 m) | (286.3 m) | (236.2 m) |
Cash From Investing Activities | (528.6 m) | (1.4 b) | (6.3 b) | (1 b) |
Long-term Borrowings | (513.9 m) | |||
Cash From Financing Activities | (553.7 m) | (417.4 m) | 4.6 b | (1.6 b) |
Interest Paid | 90.8 m | 196.2 m | 243.3 m | 527.2 m |
Income Taxes Paid | 291.9 m | 294.6 m | 361.1 m | 373 m |
Free Cash Flow | 2.3 b | 3 b | 2.8 b | 4.2 b |
| $, USD | Y, 2016 |
|---|---|
EV/EBIT | 31.2 x |
EV/CFO | 24.8 x |
EV/FCF | 23.4 x |
Revenue/Employee | 1.6 m |
Debt/Equity | 0.1 x |
Financial Leverage | 4.3 x |
Celgene Corporation Operating Metrics
Celgene Corporation Market Value History
Celgene Corporation Median Salaries
Source: 55 public H-1B filings from Celgene Corporation
